Pfizer Inc (PFE) Down 0.94%

Pfizer Inc 4 Hour Price Update

Updated August 27, 2020 04:32 PM GMT (12:32 PM EST)

PFE’s price is down $-0.21 (-0.55%) over the past four hours of trading. For context, Pfizer Inc’s peers in the in the Pharmaceutical Products industry are down -0.99% on average in this time, while its peers in the broader Healthcare sector are down by an average of -1%.

Pfizer Inc Daily Price Recap

Pfizer Inc came into today down 0.94% ($0.36) from the open of yesterday, marking the 3rd day in a row a decrease has occurred. The change in price came along side change in volume that was down 8.18% from previous day, but up 37.65% from the Wednesday of last week. Below is a daily price chart of Pfizer Inc.


Pfizer Inc Technical Analysis

Coming into today Pfizer Inc is now close to its 20 day averages, located at 38.39 respectively, and thus may be at a key juncture along those timeframes. Volatility for Pfizer Inc has been contracting over the past two weeks relative to volatility over the past month. Whether volatility reverts will be something to watch. Trend traders will want to observe that the strongest trend appears on the 30 day horizon; over that time period, price has been moving up. Or to view things another way, note that out of the past 30 days Pfizer Inc’s price has gone down 16 them.

Overheard Around the Web

Here’s what one trader on StockTwits recently had to say in regards to PFE:

    $SRNE Read this:

    $PFE or any other big bio wont wait until $SRNE comes up with a major breakthrough or becomes a $35 company… they will buy it on the cheap and we should expect to see offers coming in September. In all likelihood they will sell to a big bio for 2 reasons:
    1) financially they are on borrowed money and it is Henry's job to maximize shareholder value (As well as his own)
    2) the bidding for them should be strong as they are the leader in their space. Their library of genetic reference and the tools they have as well as patents and agreements with other companies is all added value to any big bio

    I see this to be the direction we go… I expect a buyout @ $8- $10Bil = $25-$35 PT